Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Lund – page 22

327 clinical trials in Lund, Sweden across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Lund at a glance
327
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

327 trials in Lund

Open in trial search

Chronic kidney disease+1

Not recruiting

Study on Finerenone for Children with Chronic Kidney Disease and Proteinuria Using ACEI or ARB

Investigational
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Finerenone
  • Sponsor:Bayer AG

Study on the Safety and Effectiveness of Adding Hydroxycarbamide to Standard Treatment with Cytarabine and Daunorubicin for Adults with Newly Diagnosed Acute Myeloid Leukemia

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Karolinska University Hospital

Plasma cell myeloma+1

Not recruiting

Study Comparing Ciltacabtagene Autoleucel with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed and Lenalidomide-Refractory Multiple Myeloma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Janssen Cilag International

Migraine+1

Not recruiting

Study of Eptinezumab as Add-on Treatment for Prevention of Migraine in Adults with Both Migraine and Medication Overuse Headache

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Eptinezumab
  • Sponsor:H. Lundbeck A/S

Hypercholesterolaemia

Not recruiting

Study on Evolocumab for Reducing Cardiovascular Events in Patients with Acute Myocardial Infarction

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Study on the Safety and Effectiveness of Epcoritamab with R-CHOP for Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Malignant melanoma+1

Not recruiting

Study Comparing Relatlimab and Nivolumab Combination vs. Nivolumab Alone for Patients with Advanced Melanoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Plasma cell myeloma

Not recruiting

Study Comparing Bortezomib, Lenalidomide, and Dexamethasone with Ciltacabtagene Autoleucel for Newly Diagnosed Multiple Myeloma Patients Not Planning Stem Cell Transplant

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Janssen Cilag International

Cardiac amyloidosis

Not recruiting

Study on the Effectiveness and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:ALXN2220
  • Sponsor:Alexion Pharmaceuticals Inc.

Study Comparing Rituximab and Zanubrutinib with Rituximab Alone for Untreated Patients with Splenic Marginal Zone Lymphoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Association International Extranodal Lymphoma Study Group (IELSG)

Study on the Safety and Effectiveness of RTP-026 for Patients with ST-Elevation Myocardial Infarction (STEMI)

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:RTP-026 sodium
  • Sponsor:ResoTher Pharma A/S

Cardiac failure chronic+1

Not recruiting

Study on the Safety of Starting Vericiguat at 5 mg in Patients with Chronic Heart Failure with Reduced Ejection Fraction

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Vericiguat
  • Sponsor:Bayer AG

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Lund

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on chronic coronary syndrome and heart failure prevention, including investigations of hyperemic responses and new combination therapies.

  • Adenosine response studies
  • Heart failure prevention trials
  • Lipoprotein management

Advanced cardiovascular research exploring novel treatment approaches for various cardiac conditions.

02 Oncology Studies

Comprehensive research in multiple cancer types, including melanoma, leukemia, and colorectal cancer, testing innovative therapeutic approaches.

  • Immunotherapy trials
  • Blood cancer treatments
  • Targeted therapy studies

Focus on developing more effective and personalized cancer treatments.

03 Mental Health & Neurology

Groundbreaking research in mental health conditions, including studies of anorexia nervosa and major depressive disorder.

  • Psychedelic therapy research
  • Depression treatment studies
  • Innovative therapeutic approaches

Exploring novel treatment modalities for complex psychiatric conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.